These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7530959)

  • 1. Vimentin expression, proliferating cell nuclear antigen and flow cytometric factors. Prognostic role in breast cancer.
    Russo A; Bazan V; Morello V; Tralongo V; Nagar C; Nuara R; Dardanoni G; Bazan P; Tomasino RM
    Anal Quant Cytol Histol; 1994 Oct; 16(5):365-74. PubMed ID: 7530959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of integrated morpho-biological indicators in breast cancer.
    Tomasino RM; Russo A; Bazan V; Morello V; Tralongo V; Nagar C; Salvato M; Taormina P; Marrazzo A; Nuara R
    In Vivo; 1993; 7(6B):601-5. PubMed ID: 7514895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and vimentin expression and various prognostic factors in breast cancer patients.
    Koutselini H; Markopoulos C; Lambropoulou S; Gogas H; Kandaraki C; Gogas J
    Cytopathology; 1995 Feb; 6(1):14-21. PubMed ID: 7734697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
    Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.
    Bellotti M; Elsner B; Kahn A; Bezodnick L; Pisilli L; Greco P
    Anal Quant Cytol Histol; 1997 Apr; 19(2):139-44. PubMed ID: 9113306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
    Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
    J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
    Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
    Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
    Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
    Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organizer regions in myofibroblasts in breast cancer. Relation to cancer cell morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis.
    Lipponen P; Aaltomaa S; Papinaho S; Syrjänen K
    Pathol Res Pract; 1993 Nov; 189(9):1030-5. PubMed ID: 8302721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.
    Dawson AE; Norton JA; Weinberg DS
    Am J Pathol; 1990 May; 136(5):1115-24. PubMed ID: 1972000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Demonstration and possible prognostic value of the nucleolar organizer region (NOR), the microtubule-associated proteins 1A/1B (MAP) and the intermediate filaments vimentin and cytokeratin 19 in invasive ductal breast carcinoma].
    Friedrich K; Sturm U; Dimmer U; Flössel C
    Zentralbl Pathol; 1994 Mar; 140(1):61-71. PubMed ID: 7515675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative activity is a significant prognostic factor in male breast carcinoma.
    Pich A; Margaria E; Chiusa L
    Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
    Siitonen SM; Kallioniemi OP; Isola JJ
    Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor proliferative fraction in infiltrating duct carcinoma.
    Kesari AL; Chellam VG; Nair PP; Madhavan J; Nair P; Nair MK; Pillai MR
    Gen Diagn Pathol; 1997 Dec; 143(4):219-24. PubMed ID: 9489954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M; Prasad S; Kalra N; Singh U; Shukla Y
    Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
    Tamaki M; Maeda S; Deguchi T; Kawada Y
    Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.